# Shanghai Pharmaceuticals

Source: https://onco.cc/companies/shanghai-pharmaceuticals/  
OnCo record `shanghai-pharmaceuticals` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Shanghai Pharmaceuticals is one of China's largest drug makers and distributors; its research arm is developing SPH4336, an oral CDK4/6 inhibitor for breast cancer.

## Summary

Shanghai Pharmaceuticals Holding, listed in Shanghai and Hong Kong, manufactures generic and innovative medicines and runs one of China's biggest pharmaceutical distribution networks. Its oncology research includes SPH4336, a selective CDK4/6 inhibitor in phase 1/2 trials with endocrine therapy in hormone receptor-positive, HER2-negative advanced breast cancer, and the PD-L1 and TIGIT programmes of its biologics subsidiaries.

## Fields

- Kind: Company
- Last checked: 2026-09-17
- Also known as: Shanghai Pharmaceuticals Holding; SPH; 上海医药; HKEX:2607; SSE:601607
- Tags: drug-maker
- HQ: Shanghai
- Type: pharma
- Website: https://www.sphchina.com/
- Ticker: HKEX:2607

## Sources

- Official website: https://www.sphchina.com/

## Connected records

- drugs: [SPH4336](https://onco.cc/drugs/sph4336/)

---
JSON: https://onco.cc/api/v1/entities/shanghai-pharmaceuticals.json